Product Information
QUETIAPINE ER 300 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.2834 per EA under NDC 50742063860. Its NADAC has been published 380 times since Dec 27, 2017.
The High Outlier badge above means this manufacturer's average price in the quetiapine fumarate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742063860
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
3/19/2025
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA208947On Market Since
8/31/2017
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 300 MG TABLET has been published 380 times since Dec 27, 2017, and over the history we have for it it has declined 73.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2834 per EA |
|---|---|
| All-time high | $1.0992 (Feb 14, 2018) |
| All-time low | $0.1954 (Nov 20, 2024) |
| Median price | $0.4063 |
| Average price | $0.4593 |
| Largest weekly change | +47.7% (Aug 21, 2024) |
| Weeks tracked | 380 |
| Tracking since | Dec 27, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 300 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.2834 per EA (NDC 50742063860), effective Apr 2, 2025.
How has the price of QUETIAPINE ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 300 MG TABLET has declined 73.2%. It has been tracked across 380 weekly CMS publications since Dec 27, 2017.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 300 MG TABLET?
Since Dec 27, 2017, the NADAC for QUETIAPINE ER 300 MG TABLET has ranged from a low of $0.1954 (Nov 20, 2024) to a high of $1.0992 (Feb 14, 2018), with a median of $0.4063 per EA.
Are there cheaper alternatives to QUETIAPINE ER 300 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, QUETIAPINE FUMARATE 300 MG TAB, is $0.1442 per EA — about 49% below QUETIAPINE ER 300 MG TABLET.
Who manufactures QUETIAPINE ER 300 MG TABLET?
QUETIAPINE ER 300 MG TABLET (NDC 50742063860) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification